Since the cost of drugs and medicine is very high, patients should be empowered and motivated to join associations, so that they can undergo standard and proven treatment policies based on the most effective drugs, as recommended by the WHO in its model list of essential medicines in partnership with government and non-government organizations to ensure the consistent availability of insulin and other anti-diabetes drugs. The gene discussed is INS; the disease is diabetes mellitus.